BiotechTube
BioCentra

BioCentra

Cranbury, United States· Est.
biocentra.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $25M

Overview

BioCentra, founded in 2003 and headquartered in Cranbury, New Jersey, with a laboratory in Houston, Texas, is a private diagnostics company. Its core innovation is the TBioScan® technology platform, designed to improve the diagnostic evaluation of mild Traumatic Brain Injury (TBI) for neurologists. The company appears to be in a commercial, revenue-generating stage, offering direct-to-consumer and physician-ordered screening tests for neurological and cardiovascular conditions. BioCentra operates a service-based business model, providing laboratory testing services directly to customers and healthcare professionals.

NeurologyCardiovascular

Technology Platform

Proprietary TBioScan® technology for advanced diagnostic assessment, initially focused on mild Traumatic Brain Injury (TBI) and extended to screening for dementia/Alzheimer's and cardiovascular diseases.

Funding History

2
Total raised:$25M
Series A$20M
Seed$5M

Opportunities

The large, underserved market for objective diagnostics in mild Traumatic Brain Injury (TBI) presents a significant opportunity, especially with growing awareness in sports and military medicine.
Additionally, the aging population and focus on early detection in dementia/Alzheimer's disease create a expanding market for accessible screening tools.

Risk Factors

Key risks include the need for robust clinical validation to drive adoption by neurologists, the challenge of securing insurance reimbursement for a new diagnostic test, and intense competition from established laboratory networks and other emerging diagnostic technologies.

Competitive Landscape

BioCentra competes in the crowded neurology diagnostics space against large national labs (Quest, LabCorp), specialized neuro-diagnostic companies, and a growing number of digital and biomarker-focused startups. Its success depends on proving TBioScan®'s clinical superiority and integrating seamlessly into physician practice.

More companies in Diagnostics & Precision Medicine →More companies in United States →